7 completed, 1 recruiting, 1 unknown. 3 Phase 3, 2 Phase 2, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 4 | 2 | Completed 1, Recruiting 1 |
Follow sarecycline: new trials by email Literature Review of sarecycline trials Research Report on sarecycline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne. Sarecycline, Doxycycline - Acne Vulgaris | Phase 4 | Recruiting | Integrative Skin Science and Research | 30 | 2026-04-20 | 2026-04-22 |
| Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion Therapy Sarecycline Tablet, Placebo tablets of Sarecycline tablets - Ischemic Stroke, Acute | Phase 2 | Unknown | Beijing Tiantan Hospital | 120 | 2023-05-07 | 2023-07-20 |
| Sarecycline Truncal Acne Safety and Efficacy Response Sarecycline - Acne Vulgaris | Completed | Angela Moore | 10 | 2021-03-09 | 2023-08-01 | |
| Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES) Sarecycline - Acne Vulgaris | Completed | Almirall, S.A. | 300 | 2021-03-09 | 2024-10-10 | |
| A Pilot Study on the Use of Seysara for Rosacea sarecycline, Centrum Adult Multivitamin - Acne Rosacea | Phase 4 | Completed | Derm Research, PLLC | 100 | 2019-04-15 | 2021-01-07 |
| A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris Sarecycline - Acne Vulgaris | Phase 3 | Completed | Almirall, S.A. | 490 | 2015-03-20 | 2019-02-01 |
| Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne Sarecycline, Placebo - Acne Vulgaris | Phase 3 | Completed | Almirall, S.A. | 968 | 2014-12-18 | 2019-02-15 |
| Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne Sarecycline, Placebo - Acne Vulgaris | Phase 3 | Completed | Almirall, S.A. | 1034 | 2014-12-03 | 2019-02-01 |
| Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris 50 mg P005672-HCl, Placebo, 100 mg P005672-HCl - Acne Vulgaris | Phase 2 | Completed | Almirall, S.A. | 285 | 2012-06-30 | 2019-02-01 |
Acne Vulgaris (7) · Ischemic Stroke (1) · Rosacea (1) · Signs and Symptoms (1)
Almirall, S.A. (5) · Angela Moore (1) · Beijing Tiantan Hospital (1) · Derm Research, PLLC (1) · Integrative Skin Science and Research (1)
United States (8) · China (1)
David Berk, MD (2) · Alexandre Kaoukhov, MD (1) · Angela Moore, MD (1) · Herman Ellman, MD (1) · Raja Sivamani, MD (1) · Yilong Wang, PhD，MD (1)
PMID 19834014, PMID 20075087, PMID 26898852, PMID 27733282, PMID 29232823, PMID 29444972, PMID 29601945, PMID 30355104, PMID 31263257, PMID 31296369, PMID 31899551, PMID 32038757, PMID 32414889, PMID 32568647